CONATUS PHARMACEUTICALS INC's ticker is and the CUSIP is 20600T908. A total of 3 filers reported holding CONATUS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $8,000 | -68.0% | 25,200 | -73.6% | 0.00% | – |
| Q2 2019 | $25,000 | -64.3% | 95,500 | +47.8% | 0.00% | -100.0% |
| Q1 2019 | $70,000 | +84.2% | 64,600 | +197.7% | 0.00% | – |
| Q4 2018 | $38,000 | -53.7% | 21,700 | +52.8% | 0.00% | -100.0% |
| Q3 2018 | $82,000 | +1540.0% | 14,200 | +1190.9% | 0.00% | – |
| Q2 2018 | $5,000 | -92.1% | 1,100 | -89.8% | 0.00% | -100.0% |
| Q1 2018 | $63,000 | -25.0% | 10,800 | -40.3% | 0.00% | 0.0% |
| Q4 2017 | $84,000 | -15.2% | 18,100 | +0.6% | 0.00% | 0.0% |
| Q3 2017 | $99,000 | +98.0% | 18,000 | +109.3% | 0.00% | 0.0% |
| Q2 2017 | $50,000 | +108.3% | 8,600 | +109.8% | 0.00% | – |
| Q1 2017 | $24,000 | -88.8% | 4,100 | -89.9% | 0.00% | -100.0% |
| Q4 2016 | $214,000 | +114.0% | 40,700 | -18.3% | 0.00% | +100.0% |
| Q3 2016 | $100,000 | +96.1% | 49,800 | +100.8% | 0.00% | 0.0% |
| Q2 2016 | $51,000 | +21.4% | 24,800 | +25.3% | 0.00% | 0.0% |
| Q1 2016 | $42,000 | +147.1% | 19,800 | +230.0% | 0.00% | – |
| Q4 2015 | $17,000 | -84.8% | 6,000 | -76.2% | 0.00% | -100.0% |
| Q3 2015 | $112,000 | -78.1% | 25,200 | -64.9% | 0.00% | -75.0% |
| Q1 2015 | $511,000 | +662.7% | 71,700 | +654.7% | 0.01% | +700.0% |
| Q4 2014 | $67,000 | +59.5% | 9,500 | +39.7% | 0.00% | 0.0% |
| Q3 2014 | $42,000 | -25.0% | 6,800 | +9.7% | 0.00% | 0.0% |
| Q2 2014 | $56,000 | – | 6,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 49,800 | $100,000 | 0.00% |
| SIMPLEX TRADING, LLC | 96 | $0 | 0.00% |